Biotech

All Articles

Biogen, UCB document period 3 lupus win after failing earlier trial

.Biogen and UCB's gamble on improving right into period 3 astride a broken study aims to have actual...

Aptadir really hopes brand-new RNA preventions can easily turn around tricky cancers

.Italian biotech Aptadir Therapeutics has actually launched with the assurance that its own pipeline...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has met its own objective in a Duchenne muscular dystrophy (DMD) study, pos...

Sanofi picks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma laye...

Achilles trickles tissue treatment course, braces for discharges after missing 'industrial practicality' targets

.Achilles Therapeutics has destroyed its strategy. The English biotech is actually quiting working o...

Aligos heralds stage 2 MASH gain, reducing liver body fat approximately 46%

.Aligos Therapies is heralding a midstage win in metabolic-dysfunction associated steatohepatitis (M...

Basilea ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand-new antifungals has gotten a substantial increase fr...

Capricor sells Europe legal rights to late-stage DMD therapy for $35M

.Having currently scooped up the united state civil rights to Capricor Rehabs' late-stage Duchenne m...

FDA scraps adcomm for Applied's rare disease medication

.After pushing back the decision date for Applied Therapeutics' metabolic disorder medication govore...

Novo inks $600M NanoVation deal to research genetic medications ex-liver

.Novo Nordisk is continuing its own press right into hereditary medicines, accepting to compensate N...